Previous 10 | Next 10 |
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients PR Newswire - The full approval of ELAHERE is based on the confirmatory MIRASOL Phase 3 trial that supports the medicine as a p...
ALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY, DRIVE INNOVATION AND LEAD WITH INTEGRITY AS IT HOSTS EXPERT LED SYMPOSIA AT AMWC 2024 PR Newswire -- Two expert-led Allergan Medical Institute (AMI) symposia will explore a personalized approach to aesthetics, featuring ...
2024-03-19 14:05:34 ET More on AbbVie AbbVie Inc. (ABBV) Barclays 26th Annual Global Healthcare Conference (Transcript) AbbVie: Comeback Expected After Humira Patent Expiration AbbVie Stock: I Was So Wrong, But This Is Way Too Fast Survey finds GLP-1 users mo...
2024-03-19 08:00:07 ET FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – March 19, 2024 – The U.S. Federal Drug Administration (FDA) has now designated psilocybin, a classical compound found in “magic mushrooms,” as a ...
2024-03-19 06:46:45 ET Summary Key BMY program revenue is at risk from loss of patent exclusivity over the next several years. The company has turned to acquisitions to fortify its pipeline and revenue streams. BMY is relying on its pipeline of new products and recent acquisit...
2024-03-19 01:45:00 ET Summary Companies are taking advantage of strong investor demand in the investment grade credit market. In just the first two months of 2024, we’ve seen nearly 200 companies issue roughly $380 billion of new bonds in the U.S. investment grade credit p...
2024-03-18 14:07:39 ET Summary The healthcare sector is overvalued by about 13% relative to 11-year averages, but overvaluation varies a lot across subsectors. Healthcare equipment has the worst value and quality scores. iShares Global Healthcare ETF is a global alternative to...
2024-03-18 13:49:14 ET Summary Schwab U.S. Dividend Equity ETF™ recently underwent its annual reconstitution, and we see many familiar names. The fund provides exposure to a value-oriented portfolio and has delivered an attractive yield of 3.77% with growth. We've conti...
2024-03-18 12:28:56 ET Summary Schwab U.S. Dividend Equity ETF™ has undergone a major change in its holdings, eliminating and replacing 23 stocks contributing 1/5 of its dividend. Four of the added stocks are flagged as very risky by Seeking Alpha's Quant rating system...
2024-03-18 06:46:25 ET Summary I have been actively reshaping my portfolio by selling off low-conviction holdings and focusing on high-growth compounders. I have reduced my holdings from roughly 90 to roughly 70 over the past 6 months or so. I am excited about my current alloc...
News, Short Squeeze, Breakout and More Instantly...
On Thursday, Evernorth Health Services said its Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs. Eve...
2024-04-26 16:07:11 ET By almost any measure, AbbVie (NYSE: ABBV) shares should have risen Friday. The pharmaceutical giant delivered first-quarter sales and earnings results that topped estimates. The decline in sales of multi-indication immunosuppressive drug Humira -- a natural r...
2024-04-26 15:15:13 ET Image source: The Motley Fool. AbbVie (NYSE: ABBV) Q1 2024 Earnings Call Apr 26, 2024 , 9:00 a.m. ET Operator Continue reading For further details see: AbbVie (ABBV) Q1 2024 Earnings Call Transcript